United States RNA-Based Vaccines Market Report 2017

August 2017 | 111 pages | ID: UE189E26FF4EN
QYResearch

Abstracts

In this report, the United States RNA-Based Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of RNA-Based Vaccines in these regions, from 2012 to 2022 (forecast).

United States RNA-Based Vaccines market competition by top manufacturers/players, with RNA-Based Vaccines sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Pfizer
• Roche
• Sanofi-Aventis
• Abbott Laboratories
• Arrowhead Pharmaceuticals
• Benitec Biopharma
• Calimmune Inc
• Dicerna
• Gradalis
• Quark
• RXi
• Senesco
• Silence Therapeutics
• Silenseed
• Tekmira
• Alnylam Pharmaceuticals

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Type I
• Type II

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of RNA-Based Vaccines for each application, including

• Cancer
• Diabetes
• Tuberculosis
• Cardiovascular Diseases
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States RNA-Based Vaccines Market Report 2017

1 RNA-BASED VACCINES OVERVIEW

1.1 Product Overview and Scope of RNA-Based Vaccines
1.2 Classification of RNA-Based Vaccines by Product Category
  1.2.1 United States RNA-Based Vaccines Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States RNA-Based Vaccines Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.1 Type I
  1.2.2 Type II
1.3 United States RNA-Based Vaccines Market by Application/End Users
  1.3.1 United States RNA-Based Vaccines Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Cancer
  1.3.3 Diabetes
  1.3.4 Tuberculosis
  1.3.5 Cardiovascular Diseases
  1.3.6 Others
1.4 United States RNA-Based Vaccines Market by Region
  1.4.1 United States RNA-Based Vaccines Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West RNA-Based Vaccines Status and Prospect (2012-2022)
  1.4.3 Southwest RNA-Based Vaccines Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic RNA-Based Vaccines Status and Prospect (2012-2022)
  1.4.5 New England RNA-Based Vaccines Status and Prospect (2012-2022)
  1.4.6 The South RNA-Based Vaccines Status and Prospect (2012-2022)
  1.4.7 The Midwest RNA-Based Vaccines Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of RNA-Based Vaccines (2012-2022)
  1.5.1 United States RNA-Based Vaccines Sales and Growth Rate (2012-2022)
  1.5.2 United States RNA-Based Vaccines Revenue and Growth Rate (2012-2022)

2 UNITED STATES RNA-BASED VACCINES MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States RNA-Based Vaccines Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States RNA-Based Vaccines Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States RNA-Based Vaccines Average Price by Players/Suppliers (2012-2017)
2.4 United States RNA-Based Vaccines Market Competitive Situation and Trends
  2.4.1 United States RNA-Based Vaccines Market Concentration Rate
  2.4.2 United States RNA-Based Vaccines Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers RNA-Based Vaccines Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES RNA-BASED VACCINES SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States RNA-Based Vaccines Sales and Market Share by Region (2012-2017)
3.2 United States RNA-Based Vaccines Revenue and Market Share by Region (2012-2017)
3.3 United States RNA-Based Vaccines Price by Region (2012-2017)

4 UNITED STATES RNA-BASED VACCINES SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States RNA-Based Vaccines Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States RNA-Based Vaccines Revenue and Market Share by Type (2012-2017)
4.3 United States RNA-Based Vaccines Price by Type (2012-2017)
4.4 United States RNA-Based Vaccines Sales Growth Rate by Type (2012-2017)

5 UNITED STATES RNA-BASED VACCINES SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States RNA-Based Vaccines Sales and Market Share by Application (2012-2017)
5.2 United States RNA-Based Vaccines Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES RNA-BASED VACCINES PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Pfizer
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 RNA-Based Vaccines Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Pfizer RNA-Based Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Roche
  6.2.2 RNA-Based Vaccines Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Roche RNA-Based Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Sanofi-Aventis
  6.3.2 RNA-Based Vaccines Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Sanofi-Aventis RNA-Based Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Abbott Laboratories
  6.4.2 RNA-Based Vaccines Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Abbott Laboratories RNA-Based Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Arrowhead Pharmaceuticals
  6.5.2 RNA-Based Vaccines Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Arrowhead Pharmaceuticals RNA-Based Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Benitec Biopharma
  6.6.2 RNA-Based Vaccines Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Benitec Biopharma RNA-Based Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Calimmune Inc
  6.7.2 RNA-Based Vaccines Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Calimmune Inc RNA-Based Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Dicerna
  6.8.2 RNA-Based Vaccines Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Dicerna RNA-Based Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Gradalis
  6.9.2 RNA-Based Vaccines Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Gradalis RNA-Based Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Quark
  6.10.2 RNA-Based Vaccines Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Quark RNA-Based Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 RXi
6.12 Senesco
6.13 Silence Therapeutics
6.14 Silenseed
6.15 Tekmira
6.16 Alnylam Pharmaceuticals

7 RNA-BASED VACCINES MANUFACTURING COST ANALYSIS

7.1 RNA-Based Vaccines Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of RNA-Based Vaccines

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 RNA-Based Vaccines Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of RNA-Based Vaccines Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES RNA-BASED VACCINES MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States RNA-Based Vaccines Sales Volume, Revenue Forecast (2017-2022)
11.2 United States RNA-Based Vaccines Sales Volume Forecast by Type (2017-2022)
11.3 United States RNA-Based Vaccines Sales Volume Forecast by Application (2017-2022)
11.4 United States RNA-Based Vaccines Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of RNA-Based Vaccines
Figure United States RNA-Based Vaccines Market Size (K Units) by Type (2012-2022)
Figure United States RNA-Based Vaccines Sales Volume Market Share by Type (Product Category) in 2016
Figure United States RNA-Based Vaccines Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of RNA-Based Vaccines by Application in 2016
Figure Cancer Examples
Table Key Downstream Customer in Cancer
Figure Diabetes Examples
Table Key Downstream Customer in Diabetes
Figure Tuberculosis Examples
Table Key Downstream Customer in Tuberculosis
Figure Cardiovascular Diseases Examples
Table Key Downstream Customer in Cardiovascular Diseases
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States RNA-Based Vaccines Market Size (Million USD) by Region (2012-2022)
Figure The West RNA-Based Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest RNA-Based Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic RNA-Based Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England RNA-Based Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US RNA-Based Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest RNA-Based Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States RNA-Based Vaccines Sales (K Units) and Growth Rate (2012-2022)
Figure United States RNA-Based Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States RNA-Based Vaccines Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States RNA-Based Vaccines Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States RNA-Based Vaccines Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States RNA-Based Vaccines Sales Share by Players/Suppliers
Figure 2017 United States RNA-Based Vaccines Sales Share by Players/Suppliers
Figure United States RNA-Based Vaccines Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States RNA-Based Vaccines Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States RNA-Based Vaccines Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States RNA-Based Vaccines Revenue Share by Players/Suppliers
Figure 2017 United States RNA-Based Vaccines Revenue Share by Players/Suppliers
Table United States Market RNA-Based Vaccines Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market RNA-Based Vaccines Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States RNA-Based Vaccines Market Share of Top 3 Players/Suppliers
Figure United States RNA-Based Vaccines Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers RNA-Based Vaccines Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers RNA-Based Vaccines Product Category
Table United States RNA-Based Vaccines Sales (K Units) by Region (2012-2017)
Table United States RNA-Based Vaccines Sales Share by Region (2012-2017)
Figure United States RNA-Based Vaccines Sales Share by Region (2012-2017)
Figure United States RNA-Based Vaccines Sales Market Share by Region in 2016
Table United States RNA-Based Vaccines Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States RNA-Based Vaccines Revenue Share by Region (2012-2017)
Figure United States RNA-Based Vaccines Revenue Market Share by Region (2012-2017)
Figure United States RNA-Based Vaccines Revenue Market Share by Region in 2016
Table United States RNA-Based Vaccines Price (USD/Unit) by Region (2012-2017)
Table United States RNA-Based Vaccines Sales (K Units) by Type (2012-2017)
Table United States RNA-Based Vaccines Sales Share by Type (2012-2017)
Figure United States RNA-Based Vaccines Sales Share by Type (2012-2017)
Figure United States RNA-Based Vaccines Sales Market Share by Type in 2016
Table United States RNA-Based Vaccines Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States RNA-Based Vaccines Revenue Share by Type (2012-2017)
Figure Revenue Market Share of RNA-Based Vaccines by Type (2012-2017)
Figure Revenue Market Share of RNA-Based Vaccines by Type in 2016
Table United States RNA-Based Vaccines Price (USD/Unit) by Types (2012-2017)
Figure United States RNA-Based Vaccines Sales Growth Rate by Type (2012-2017)
Table United States RNA-Based Vaccines Sales (K Units) by Application (2012-2017)
Table United States RNA-Based Vaccines Sales Market Share by Application (2012-2017)
Figure United States RNA-Based Vaccines Sales Market Share by Application (2012-2017)
Figure United States RNA-Based Vaccines Sales Market Share by Application in 2016
Table United States RNA-Based Vaccines Sales Growth Rate by Application (2012-2017)
Figure United States RNA-Based Vaccines Sales Growth Rate by Application (2012-2017)
Table Pfizer Basic Information List
Table Pfizer RNA-Based Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer RNA-Based Vaccines Sales Growth Rate (2012-2017)
Figure Pfizer RNA-Based Vaccines Sales Market Share in United States (2012-2017)
Figure Pfizer RNA-Based Vaccines Revenue Market Share in United States (2012-2017)
Table Roche Basic Information List
Table Roche RNA-Based Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Roche RNA-Based Vaccines Sales Growth Rate (2012-2017)
Figure Roche RNA-Based Vaccines Sales Market Share in United States (2012-2017)
Figure Roche RNA-Based Vaccines Revenue Market Share in United States (2012-2017)
Table Sanofi-Aventis Basic Information List
Table Sanofi-Aventis RNA-Based Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi-Aventis RNA-Based Vaccines Sales Growth Rate (2012-2017)
Figure Sanofi-Aventis RNA-Based Vaccines Sales Market Share in United States (2012-2017)
Figure Sanofi-Aventis RNA-Based Vaccines Revenue Market Share in United States (2012-2017)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories RNA-Based Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Abbott Laboratories RNA-Based Vaccines Sales Growth Rate (2012-2017)
Figure Abbott Laboratories RNA-Based Vaccines Sales Market Share in United States (2012-2017)
Figure Abbott Laboratories RNA-Based Vaccines Revenue Market Share in United States (2012-2017)
Table Arrowhead Pharmaceuticals Basic Information List
Table Arrowhead Pharmaceuticals RNA-Based Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Arrowhead Pharmaceuticals RNA-Based Vaccines Sales Growth Rate (2012-2017)
Figure Arrowhead Pharmaceuticals RNA-Based Vaccines Sales Market Share in United States (2012-2017)
Figure Arrowhead Pharmaceuticals RNA-Based Vaccines Revenue Market Share in United States (2012-2017)
Table Benitec Biopharma Basic Information List
Table Benitec Biopharma RNA-Based Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Benitec Biopharma RNA-Based Vaccines Sales Growth Rate (2012-2017)
Figure Benitec Biopharma RNA-Based Vaccines Sales Market Share in United States (2012-2017)
Figure Benitec Biopharma RNA-Based Vaccines Revenue Market Share in United States (2012-2017)
Table Calimmune Inc Basic Information List
Table Calimmune Inc RNA-Based Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Calimmune Inc RNA-Based Vaccines Sales Growth Rate (2012-2017)
Figure Calimmune Inc RNA-Based Vaccines Sales Market Share in United States (2012-2017)
Figure Calimmune Inc RNA-Based Vaccines Revenue Market Share in United States (2012-2017)
Table Dicerna Basic Information List
Table Dicerna RNA-Based Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Dicerna RNA-Based Vaccines Sales Growth Rate (2012-2017)
Figure Dicerna RNA-Based Vaccines Sales Market Share in United States (2012-2017)
Figure Dicerna RNA-Based Vaccines Revenue Market Share in United States (2012-2017)
Table Gradalis Basic Information List
Table Gradalis RNA-Based Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Gradalis RNA-Based Vaccines Sales Growth Rate (2012-2017)
Figure Gradalis RNA-Based Vaccines Sales Market Share in United States (2012-2017)
Figure Gradalis RNA-Based Vaccines Revenue Market Share in United States (2012-2017)
Table Quark Basic Information List
Table Quark RNA-Based Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Quark RNA-Based Vaccines Sales Growth Rate (2012-2017)
Figure Quark RNA-Based Vaccines Sales Market Share in United States (2012-2017)
Figure Quark RNA-Based Vaccines Revenue Market Share in United States (2012-2017)
Table RXi Basic Information List
Table Senesco Basic Information List
Table Silence Therapeutics Basic Information List
Table Silenseed Basic Information List
Table Tekmira Basic Information List
Table Alnylam Pharmaceuticals Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of RNA-Based Vaccines
Figure Manufacturing Process Analysis of RNA-Based Vaccines
Figure RNA-Based Vaccines Industrial Chain Analysis
Table Raw Materials Sources of RNA-Based Vaccines Major Players/Suppliers in 2016
Table Major Buyers of RNA-Based Vaccines
Table Distributors/Traders List
Figure United States RNA-Based Vaccines Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States RNA-Based Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States RNA-Based Vaccines Price (USD/Unit) Trend Forecast (2017-2022)
Table United States RNA-Based Vaccines Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States RNA-Based Vaccines Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States RNA-Based Vaccines Sales Volume (K Units) Forecast by Type in 2022
Table United States RNA-Based Vaccines Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States RNA-Based Vaccines Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States RNA-Based Vaccines Sales Volume (K Units) Forecast by Application in 2022
Table United States RNA-Based Vaccines Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States RNA-Based Vaccines Sales Volume Share Forecast by Region (2017-2022)
Figure United States RNA-Based Vaccines Sales Volume Share Forecast by Region (2017-2022)
Figure United States RNA-Based Vaccines Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources